Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
A clinical perspective on cell markers in acute lymphocytic leukemia
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A clinical perspective on cell markers in acute lymphocytic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Lymphoblastic Leukemia
100%
Cell Markers
100%
Clinical Perspective
100%
T Cells
66%
B Cells
33%
Poor Risk
33%
Clinical Features
33%
Prognostic Features
33%
New Patients
16%
Poor Response
16%
Nervous System Diseases
16%
Remission
16%
Non-Hodgkin Lymphoma
16%
Prognostic Significance
16%
Treatment Failure
16%
Erythrocytes
16%
Classification System
16%
White Blood Cell Count
16%
Response to Therapy
16%
Clinical Determinants
16%
Marker Pattern
16%
Rosette
16%
Five Cells
16%
Reliable Indicator
16%
Mediastinal Mass
16%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Cell Marker
100%
T Cell
66%
Disease
50%
B Cell
33%
Clinical Feature
33%
Leukocyte
16%
Cell Count
16%
Erythrocyte
16%
Central Nervous System Disease
16%
Non-Hodgkin Lymphoma
16%
Rosette Formation
16%
Mediastinum Mass
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Cell Marker
100%
Disease
50%
Clinical Feature
33%
Remission
16%
Nonhodgkin Lymphoma
16%
Central Nervous System Disease
16%
Mediastinum Mass
16%